1 Kerbala Journal of Pharmaceutical Sciences. No. (18) (ة انعذدذلو انص يجهة كزبلء نهعهو18 ) 2020 Review Article Ophthalmic Dosage Forms Duaa J. Al-Tamimi 1 , Afaq M. Ammoo 1 , Mays E. Alani 1 , Jaafar J. Ibraheem 2 1 Department of Pharmacy, Al-Rasheed University College, Baghdad, Iraq. 1 Department of Pharmacy, Al-Rasheed University College, Baghdad, Iraq. 1 Department of Pharmacy, Al-Rasheed University College, Baghdad, Iraq. 2 Department of Pharmacy, College of Pharmacy, Alfarahidi University, Baghdad, Iraq; * Corresponding Author: drjaafarjaber@yahoo.com Received (April-2020), Accepted (April-2020) Abstract Topical dosage forms represent about 90% of the formulations available in market. Since many years ago till now, ophthalmic dosage forms elucidate major challenges in clinical and pharmaceutical fields, thought a lot of progress and advanced technology have been achieved to improve the currently available ophthalmic drug delivery systems. Generally, the ocular diseases are complicated and difficult to treat. Besides, the ophthalmic dosage forms should be sterile, isotonic, safe and non-allergic for the patients. This review article briefly introduces different types of ophthalmic dosage forms and the advantages and limitations of each. Key words: Ophthalmic, dosage forms, drug delivery system. Conflict of Interests: None. لعيوننيه المخصصه لصيذل الشكال ال مي التميبر ابراهيماء جعفر جا دع, مي التميبر ابراهيملعاني, جعفر جاد ايس عمالجنابي, مهذي عمو افاق م ا خلصه أل  حوانوظع انذلل انصلشكا تشكم ا00  فاات ونحذ الو سذ عق وي انسو فوجودت انبا انتزك يائ بان انتقذو بانزغى يذل وانصزلت انسزجازفى انم تحذي كب تشكو نهعخصص انذلحعزات انصست ان  فا عايبصور وو نهعخصص انذلل انصلشكا اصم نتحسز انهذي ح انكبونوج انتك يعقذو ايزاض انع طز نهاسب انحس ول تسب اي تكوجب اى وج انى انتعقحتا توزات انع يستحع انى ا بالظافذا انعلج وصعب تحذدانعوايم انتائذ و انى انفو بالظافو نهعخصص انذلل انصقذو شزح يختصز نلشكا تزاجع انذ  نذنك فا انذ ال استعحعزاتست 1. Introduction Ophthalmic drug delivery systems might be preferable relative to other delivery systems in spite of its potential risks and complications (1, 2). Moreover, in comparison to oral drug delivery systems, ocular drug delivery may provide equivalent or better bioavailability in the eye (3). Many approaches were tested for the improvement of the rate and/or the extent of bioavailability